ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print February 6, 2008, 10.1183/09031936.00089807
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Esther, C. R.
Right arrow Articles by Boucher, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Esther, C. R., Jr
Right arrow Articles by Boucher, R. C.
Eur Respir J 2008; 31:949-956
Copyright ©ERS Journals Ltd 2008

Extracellular purines are biomarkers of neutrophilic airway inflammation

C. R. Esther, Jr1, N. E. Alexis2, M. L. Clas1, E. R. Lazarowski3, S. H. Donaldson3, C. M. Pedrosa Ribeiro3, C. G. Moore4, S. D. Davis1 and R. C. Boucher3

1 Pediatric Pulmonology, 2 Center for Environmental Medicine, Asthma and Lung Biology (CEMALB), 3 Cystic Fibrosis (CF) Research Center, and 4 Division of General Medicine and Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

CORRESPONDENCE: C. R. Esther Jr, Pediatric Pulmonology, 5th Floor Bioinformatics, CB#7220, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7220, USA. Fax: 1 9199666179. E-mail: Charles_Esther{at}med.unc.edu

Keywords: Biomarker, bronchoalveolar lavage fluid, cystic fibrosis, exhaled breath condensate, inflammation, purinergic signalling

Received: July 16, 2007
Accepted January 20, 2008

Purinergic signalling regulates airway defence mechanisms, suggesting that extracellular purines could serve as airway inflammation biomarkers in cystic fibrosis (CF).

The purines adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP) and adenosine were measured in sputum from 21 adults (spontaneously expectorated from seven CF patients, induced from 14 healthy controls) to assess normal values and CF-associated changes. Subsequently, purine levels were measured in bronchoalveolar lavage fluid (BALF) from 37 children (25 CF patients, 12 disease controls) and compared with neutrophil counts, presence of airway infection and lung function. To noninvasively assess airway purines, ATP levels were measured using luminometry in exhaled breath condensate (EBC) from 14 children with CF and 14 healthy controls, then 14 CF children during a pulmonary exacerbation.

Both ATP and AMP were elevated in sputum and BALF from CF subjects compared with controls. In BALF, ATP and AMP levels were inversely related to lung function and strongly correlated with neutrophil counts. In EBC, ATP levels were increased in CF relative to controls and decreased after treatment of CF pulmonary exacerbation.

The purines adenosine triphosphate and adenosine monophosphate are candidate biomarkers of neutrophilic airways inflammation. Measurement of purines in sputum or exhaled breath condensate may provide a relatively simple and noninvasive method to track this inflammation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the European Respiratory Society.